600613.SH
神奇制药
SSE · Healthcare · Drug Manufacturers - General · CN
CNY 9.90
+10.00%Year over year
Reported trailing growth
- Revenue
- -3.0%
- EBITDA
- —
- EBIT
- -8.4%
- EPS
- -47.4%
- Free cash flow
- +89.5%
- Operating cash flow
- +42.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -6.5%
- EBITDA
- -0.4%
- EBIT
- +3.9%
- Net income
- -7.6%
- EPS
- -8.0%
- Free cash flow
- -32.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026